Cargando…
hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation
Stem cell therapies for neurological disorders are rapidly moving towards use in clinical trials. Before initiation of clinical trials, extensive pre-clinical validation in appropriate animal models is essential. However, grafts of human cells into the rodent brain are rejected within weeks after tr...
Autores principales: | Heuer, Andreas, Kirkeby, Agnete, Pfisterer, Ulrich, Jönsson, Marie E., Parmar, Malin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920671/ https://www.ncbi.nlm.nih.gov/pubmed/27235932 http://dx.doi.org/10.1016/j.expneurol.2016.05.027 |
Ejemplares similares
-
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson’s Disease
por: Kirkeby, Agnete, et al.
Publicado: (2017) -
Target‐specific forebrain projections and appropriate synaptic inputs of hESC‐derived dopamine neurons grafted to the midbrain of parkinsonian rats
por: Cardoso, Tiago, et al.
Publicado: (2018) -
Deconvolution of spatial sequencing provides accurate characterization of hESC-derived DA transplants in vivo
por: Rájová, Jana, et al.
Publicado: (2023) -
A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants
por: Aldrin-Kirk, Patrick, et al.
Publicado: (2021) -
Early Acquisition of Neural Crest Competence During hESCs Neuralization
por: Curchoe, Carol Lynn, et al.
Publicado: (2010)